changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
Recommended Acquisition (the "Recommended Acquisition") by BTG plc ("BTG") of Biocompatibles International plc ("Biocompatibles").
THIS SECTION OF THE WEBSITE (THE "MICRO-SITE") CONTAINS ANNOUNCEMENTS, DOCUMENTS AND INFORMATION (TOGETHER THE "INFORMATION") RELATING TO THE RECOMMENDED ACQUISITION BY BTG OF ALL OF THE ISSUED AND TO BE ISSUED SHARE CAPITAL OF BIOCOMPATIBLES. THE INFORMATION IS BEING MADE AVAILABLE ON THE MICRO-SITE IN GOOD FAITH AND FOR INFORMATION PURPOSES ONLY, AND ITS AVAILABILITY IS SUBJECT TO THE TERMS AND CONDITIONS SET OUT BELOW.
ACCESS TO THE MICRO-SITE MAY BE RESTRICTED UNDER SECURITIES LAWS IN CERTAIN JURISDICTIONS. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS (INCLUDING THAT YOU ARE NOT RESIDENT IN SUCH A JURISDICTION), BEFORE YOU MAY OBTAIN ACCESS TO THE INFORMATION. THE INFORMATION IS NOT DIRECTED AT, AND IS NOT INTENDED TO BE ACCESSIBLE BY, PERSONS RESIDENT IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION.
Basis of access to the Micro-Site
Please read this notice carefully before clicking "I agree" or "I do not agree" below. This notice applies to all persons who view the Micro-site and, depending on where you live, it may affect your rights. This notice may be amended or updated by BTG from time to time and it should be read carefully in full each time you wish to view the Micro-Site. In addition, the content of the Micro-Site, and its accessibility by certain persons, may be amended at any time in whole or in part at the sole discretion of BTG.
The full terms and conditions of the Recommended Acquisition will be set out in a prospectus and a class 1 circular, which are proposed to be published by BTG in due course, and a scheme document, which is proposed to be published by Biocompatibles in due course. In deciding whether or not to vote in favour of the Recommended Acquisition, Biocompatibles shareholders should rely only on the information contained and procedures described in the prospectus and the scheme document.
The Information is not for publication or distribution, directly or indirectly, in or into any jurisdiction where it would be unlawful to do so. The Information does not constitute or form part of an offer to sell, or a solicitation of an offer to buy, any securities, or a solicitation of any votes attaching to securities that are the subject of the Recommended Acquisition, in any jurisdiction where it would be unlawful to do so. In particular, BTG shares have not been and are not currently intended to be registered under the securities laws or regulations of the United States, and may not be offered or sold in any jurisdiction where it would be unlawful to do so absent registration or an applicable exemption from the securities laws or regulations of such jurisdictions. If downloading or viewing the Information would result in a breach of any such securities laws or regulations, or you are in any doubt as to whether you are permitted to download or view the Information, please exit this webpage by clicking on the "I do not agree" box below. By clicking on the "I agree" box below, you certify that you will not forward, transmit or show the Information to any person. In particular, you certify that you will not forward or transmit the Information to any jurisdiction where it would be unlawful to do so. Failure to comply with any such restrictions may constitute a violation of the laws and/or regulations of any such jurisdiction.
Cautionary note on forward looking statements
Certain of the documents contained or referred to in the Micro-Site contain forward-looking statements with respect to certain aspects of BTG's business, strategy or plans and its expectations relating to the Recommended Acquisition. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts and may include statements about the beliefs and expectations of BTG and/or its management. Forward-looking statements often use words such as "anticipate", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "will", "may", "should", "would", "could" or other words of similar meaning, but the use of such words is not the exclusive means of identifying such statements. By their nature, forward-looking statements involve risk and uncertainty, because they relate to events and depend on circumstances that may or may not occur in the future. The factors described in the context of such forward-looking statements could cause actual results and developments to differ materially from those expressed in or implied by such forward-looking statements. BTG assumes no obligation to update or correct the information contained in this Micro-Site (except to the extent legally required). Unless expressly stated otherwise, no statement contained or referred to in the Micro-Site is intended to be a profit forecast and no statement should be interpreted to mean that earnings or the earnings per share for the current or future financial periods will necessarily be greater than those for the relevant preceding financial period.
Confirmation of understanding and acceptance of this notice
By clicking on "I agree" below, you confirm that you have read, understood and agree to be bound by the terms of the notice set out above and that you are not in, or a resident of, any jurisdiction where to download or view the Information would constitute a breach of securities law or regulation in that jurisdiction.
If you click "I do not agree" below, we will be unable to provide you with access to the Information and you will be redirected to the BTG homepage.
24 January 2011
In this section you will find all the public documentation relating to the recommended offer for Biocompatibles International plc.
28 January 2011 Offer Update - Admission of New BTG Shares (PDF - 13.8KB)
27 January 2011 Offer Update - Scheme Effective (PDF - 10.9KB)
24 January 2011 Offer Update - Court sanction of the Scheme of Arrangement and timetable update (PDF - 15.4KB)
06 January 2011 Offer Update - Results of BTG Shareholder Meeting (PDF - 31.4KB)
10 December 2010 Circular to Shareholders and Notice of General Meeting (PDF - 337KB)
10 December 2010 Prospectus for Biocompatibles Acquisition (PDF - 2.3MB)
10 December 2010 Scheme Document issued by Biocompatibles (PDF - 979KB)
10 December 2010 Offer Update - Posting of the Scheme Document (PDF - 41KB)
19 November 2010 Audio Webcast - Recommended Acquisition by BTG plc of Biocompatibles International plc
19 November 2010 Investor Presentation - Recommended Acquisition by BTG plc of Biocompatibles International plc (PDF - 1.1MB)
19 November 2010 Recommended Acquisition by BTG plc of Biocompatibles International plc (PDF - 311KB)
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com